Filing Details
- Accession Number:
- 0001628280-21-018595
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-14 17:12:23
- Reporting Period:
- 2021-09-10
- Accepted Time:
- 2021-09-14 17:12:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1600620 | Aurinia Pharmaceuticals Inc. | AUPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1837648 | Bindert Robert Huizinga | #1203-4464 Markham Street Victoria A1 V8Z7X8 | Evp Of Research | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-09-10 | 5,000 | $19.83 | 133,592 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-09-10 | 5,000 | $19.76 | 128,592 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-09-14 | 22,500 | $21.75 | 106,092 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.